Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular Psoriasis
NCT06886009 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2026-03-31
Summary
The primary and secondary objectives are to respectively monitor the safety and effectiveness of Spesolimab IV in Korean patients with flares with generalized pustular psoriasis (GPP) in a routine medical practice.
Conditions
- Generalized Pustular Psoriasis
Interventions
- DRUG
-
Spevigo®
Intravenous
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-31
- Primary Completion
- 2029-06-08
- Completion
- 2029-06-08
Countries
- South Korea
Study Locations
More Related Trials
-
Topical CP-690,550 For Chronic Plaque Psoriasis
NCT00678561 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy and Safety of Investigational Treatment in Patients With Nail Psoriasis
NCT05072886 ·Status: UNKNOWN ·Phase: PHASE1
-
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01276639 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis
NCT04594928 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
NCT01815424 ·Status: COMPLETED ·Phase: PHASE3
-
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01163253 ·Status: TERMINATED ·Phase: PHASE3
-
Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00678210 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis
NCT01782937 ·Status: COMPLETED ·Phase: PHASE3
-
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
NCT03210961 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)
NCT00683930 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Clinical Study of KHK 4827
NCT02052609 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Study of Psoriasis Severity Assessment Tools
NCT02655705 ·Status: COMPLETED ·Phase: PHASE4
-
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
NCT01230138 ·Status: COMPLETED ·Phase: PHASE2
-
PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis
NCT04513847 ·Status: COMPLETED
-
A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
NCT01186744 ·Status: COMPLETED ·Phase: PHASE3
-
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01309737 ·Status: COMPLETED ·Phase: PHASE3
-
AGN-242428 in the Treatment of Plaque Psoriasis
NCT03339999 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis
NCT02995473 ·Status: COMPLETED ·Phase: PHASE2
-
Sulodexide in Controlling the Recurrence of Psoriasis
NCT06982196 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast)
NCT06905028 ·Status: RECRUITING ·Phase: NA
-
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis
NCT01710046 ·Status: COMPLETED ·Phase: PHASE2
-
A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris
NCT01116895 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
NCT02949388 ·Status: COMPLETED ·Phase: PHASE2
-
Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
NCT05144165 ·Status: UNKNOWN
-
Body PSOriasis: Long-term Relapse CONTROL
NCT03402828 ·Status: COMPLETED